The idea behind 42PLUS1 is simple.
42 is known as the answer to the ultimate question of life, the universe, and everything. This excerpt comes from the movie “Hitchhiker’s Guide to the Galaxy”. When it comes to the big big big startup universe, we all look for a specific answer to one question: “How am I to find investors and become visible among the many stars of the ever-expanding startup universe?!
We are happy for the opportunity to feature so many awesome companies over the past years and see them succeed afterwards.
The 2023 winner(s) will be elected in the grand finale taking place Oct. 5, during DxPx EU 2023!
The Future of Cell and Gene Therapy is Automated
Limula offers a modular solution for on-demand and at-scale manufacturing of cell therapies in a single device.
Better blood collection for the future of healthcare.
“With the Cinna™, we are closing the gap in at-home testing”
Esya utilizes patented intracellular analytics utilizing DNA nanoprobes and AI to diagnose Alzheimer’s Disease before symptoms are exhibited.
Toku Eyes has created a multi-modal AI platform that uses retinal images to provide instant healthcare diagnostics, personalized prognostics, and general health risk assessments, screening for preventable blindness and cardiovascular disease risk.
Meet our first ever 42PLUS1 winner – Alertgy
Alertgy, presented by the CEO Marc Rippen, has developed a 100% non-invasive, real-time, real blood glucometer that lasts a long time. As a cutting-edge biotech company, they’re working to revolutionize the way diabetics and pre-diabetics manage their diabetes.